Breaking News“Most Expensive Stock I’ve Ever Seen”: Palantir Smashes Estimates But Stock Fades After Hours Surge As Valuation Questions Swirl
Breaking NewsNovo Nordisk Plunges After Ozempic Pill Fails Alzheimer’s Trials – Shares Suffer Worst Year Ever